Highlights
New Otago biotech startup targets cancer
Amaroq Therapeutics, a new biotech startup company with the goal of developing targeted drugs for cancer, has been awarded significant investment funds in 2021.
read the full story
A record year for commercialisation
In 2018, NZ$58M was raised by companies in New Zealand and overseas to take MWC discoveries through to the clinic – a new record in terms of annual investment in new medicines inve
read the full story